BioRem Inc. (TSXV:BRM)

Canada flag Canada · Delayed Price · Currency is CAD
3.040
-0.050 (-1.62%)
Jun 10, 2026, 3:59 PM EST
Market Cap49.30M +51.7%
Revenue (ttm)44.44M +22.7%
Net Income4.98M +82.0%
EPS0.27 +89.1%
Shares Out 16.22M
PE Ratio11.27
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,116
Open3.090
Previous Close3.090
Day's Range3.040 - 3.090
52-Week Range1.840 - 3.570
Beta0.87
Analystsn/a
Price Targetn/a
Earnings DateAug 24, 2026

About BioRem

BioRem Inc., a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds, and hazardous air pollutants. The company offers biofilters; biotrickling filters; multi-stage systems; biogas desulfurization systems; dry scrubber adsorption systems; and cannabis odor control systems. It also sells biofiltration media products under the BIOSORBENS, XLD, BIOPAK, BIOROLL, and BIOBLOK names. The company operates in Canada, the United States... [Read more]

Founded 1990
Employees 34
Stock Exchange TSX Venture Exchange
Ticker Symbol BRM
Full Company Profile

Financial Performance

In 2025, BioRem's revenue was 42.36 million, an increase of 13.19% compared to the previous year's 37.42 million. Earnings were 4.82 million, an increase of 58.25%.

Financial Statements

News

BioRem Registration statement: Q1 2026

BioRem filed a registration statement on May 14, 2026, providing details about a securities offering with the SEC.

27 days ago - Filings

BioRem Registration statement: Q1 2026

BioRem filed a registration statement on May 14, 2026, providing details about a securities offering with the SEC.

27 days ago - Filings

BioRem Earnings release: Q1 2026

BioRem released its Q1 2026 earnings on May 14, 2026, summarizing the period's financial results.

27 days ago - Filings

BioRem Registration statement: Q4 2025

BioRem filed a registration statement on April 20, 2026, providing details about a securities offering with the SEC.

7 weeks ago - Filings

BioRem Registration statement: Q4 2025

BioRem filed a registration statement on April 20, 2026, providing details about a securities offering with the SEC.

7 weeks ago - Filings

BioRem Earnings release: Q4 2025

BioRem released its Q4 2025 earnings on April 20, 2026, summarizing the period's financial results.

7 weeks ago - Filings

BioRem Registration statement: Q3 2025

BioRem filed a registration statement on November 16, 2025, providing details about a securities offering with the SEC.

7 months ago - Filings

BioRem Registration statement: Q3 2025

BioRem filed a registration statement on November 16, 2025, providing details about a securities offering with the SEC.

7 months ago - Filings

BioRem Earnings release: Q3 2025

BioRem released its Q3 2025 earnings on November 16, 2025, summarizing the period's financial results.

7 months ago - Filings

BioRem Transcript: Planet MicroCap Showcase: TORONTO 2025

Management reduced outstanding shares by 60% through a strategic buyback, strengthening capital structure. The business is experiencing strong organic growth, driven by new products and services, with a record backlog and expanding service revenue. Market demand is supported by infrastructure upgrades, regulatory trends, and a disciplined M&A approach.

8 months ago - Transcripts

BioRem Earnings release: Q2 2025

BioRem released its Q2 2025 earnings on August 25, 2025, summarizing the period's financial results.

10 months ago - Filings

BioRem Registration statement: Q2 2025

BioRem filed a registration statement on August 25, 2025, providing details about a securities offering with the SEC.

10 months ago - Filings

BioRem Registration statement: Q2 2025

BioRem filed a registration statement on August 25, 2025, providing details about a securities offering with the SEC.

10 months ago - Filings

BIOREM Reports Strong First Quarter Financial Results and Continued Growth in Order Backlog

GUELPH, ON , May 28, 2024 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("BIOREM" or "the Company") today announced results for the three month period ended March 31, 2024. BIOREM's complete 2024 first quart...

2 years ago - PRNewsWire